Peptide portfolio: Biohacker medicine cabinet

Biohackers aren’t sitting on the sidelines. They’re building full “medicine cabinets” of peptides, stacking research compounds for everything from muscle growth to sharper cognition. The old days of single-compound experiments are over. Now, it’s about mixing, matching, and personalizing stacks.

What’s inside a typical peptide portfolio? It’s a mixed bag. Here’s what’s showing up most often:

Researchers are going beyond one-size-fits-all. The real trend is stacking—testing combinations, tracking response, and swapping peptides based on individual goals. Managing multiple research peptides at once means more variables, but it also means more insight. Biohackers share protocols, track biomarkers, and swap notes on mixing, reconstitution, and timing.

Key takeaway: Peptide research isn’t just about what one compound can do. It’s about what happens when you run a smart, well-chosen stack. The self-experimentation culture is pushing innovation faster than traditional clinical trials.

If you’re looking to build your own portfolio or see what’s possible, the peptide research index is a good place to start. Curious about sourcing or comparing vendors? Check out the vendor directory.

Biohacker cabinets are getting crowded—and smarter. This is where the next wave of discovery is happening.